KZR RSI Chart
Last 7 days
10.2%
Last 30 days
15.5%
Last 90 days
14.1%
Trailing 12 Months
-74.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 0 | 0 | 0 | 7.0M |
2022 | 0 | 0 | 0 | 0 |
2021 | 0 | 0 | 0 | 0 |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Aug 15, 2023 | morningside venture investments ltd | gifted | - | - | -3,500,000 | - |
Jul 20, 2023 | kirk christopher j. | acquired | 44,055 | 0.9 | 48,950 | - |
Feb 06, 2023 | morningside venture investments ltd | sold | -275,320 | 6.883 | -40,000 | - |
Feb 03, 2023 | morningside venture investments ltd | sold | -178,650 | 7.146 | -25,000 | - |
Feb 02, 2023 | morningside venture investments ltd | sold | -359,500 | 7.19 | -50,000 | - |
Feb 01, 2023 | morningside venture investments ltd | sold | -278,000 | 6.95 | -40,000 | - |
Jan 31, 2023 | morningside venture investments ltd | sold | -212,400 | 7.08 | -30,000 | - |
Jan 30, 2023 | morningside venture investments ltd | sold | -207,300 | 6.91 | -30,000 | - |
Jan 25, 2023 | morningside venture investments ltd | sold | -342,500 | 6.85 | -50,000 | - |
Jan 24, 2023 | morningside venture investments ltd | sold | -558,400 | 6.98 | -80,000 | - |
Which funds bought or sold KZR recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Mar 22, 2024 | PNC FINANCIAL SERVICES GROUP, INC. | new | - | 177 | 177 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | added | 0.75 | -715,930 | 2,902,340 | -% |
Mar 01, 2024 | GOLDMAN SACHS GROUP INC | reduced | -36.07 | -809,289 | 838,868 | -% |
Feb 28, 2024 | AMERICAN INTERNATIONAL GROUP, INC. | reduced | -0.4 | -8,776 | 33,607 | -% |
Feb 16, 2024 | GSA CAPITAL PARTNERS LLP | new | - | 247,000 | 247,000 | 0.02% |
Feb 16, 2024 | PRICE T ROWE ASSOCIATES INC /MD/ | unchanged | - | -12,000 | 44,000 | -% |
Feb 15, 2024 | Palo Alto Investors LP | sold off | -100 | -780,878 | - | -% |
Feb 15, 2024 | BARCLAYS PLC | added | 678 | 78,000 | 93,000 | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | new | - | 65,780 | 65,780 | -% |
Feb 15, 2024 | Legal & General Group Plc | unchanged | - | -1,653 | 6,456 | -% |
Unveiling Kezar Life Sciences Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Kezar Life Sciences Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 42.3B | 6.8B | -8.96 | 6.17 | ||||
HILS | 22.4B | 152.6K | -2.4K | 146.8K | ||||
ALNY | 19.4B | 1.8B | -44.17 | 10.64 | ||||
BMRN | 16.7B | 2.4B | 99.73 | 6.91 | ||||
INCY | 12.8B | 3.7B | 21.46 | 3.47 | ||||
MID-CAP | ||||||||
APLS | 7.1B | 396.6M | -13.34 | 17.78 | ||||
BBIO | 5.4B | - | -8.31 | 60.35 | ||||
AXSM | 3.8B | 270.6M | -15.68 | 13.86 | ||||
ARWR | 3.6B | 240.7M | -11.98 | 14.77 | ||||
ACAD | 3.0B | 726.4M | -48.93 | 4.13 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 398.2M | 26.85 | 4.82 | ||||
NVAX | 678.8M | 983.7M | -1.25 | 0.69 | ||||
CRBP | 373.2M | 881.7K | -8.37 | 466.16 | ||||
INO | 304.5M | 4.9M | -2.25 | 62.57 | ||||
IBIO | 11.8M | 2.1M | -0.43 | 2.14 |
Kezar Life Sciences Inc News
Income Statement (Quarterly) | |||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2021Q4 |
Revenue | -100.0% | - | 7,000 | - | - | - | - |
Operating Expenses | 6.3% | 34,589 | 32,527 | 26,784 | 24,524 | 20,034 | 14,103 |
S&GA Expenses | -34.5% | 5,760 | 8,789 | 5,785 | 6,206 | 5,175 | 4,322 |
R&D Expenses | -4.6% | 22,642 | 23,738 | 20,999 | 18,318 | 14,859 | 9,781 |
Interest Expenses | 0.8% | 399 | 396 | 385 | 370 | 349 | 159 |
Net Income | -39.6% | -32,260 | -23,103 | -24,308 | -22,199 | -18,181 | -14,212 |
Net Income Margin | -Infinity% | -14.55* | - | - | - | - | - |
Free Cashflow | 6.7% | -18,981 | -20,341 | -22,976 | -21,157 | -16,226 | -11,347 |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | -11.3% | 221 | 249 | 263 | 284 | 300 | 305 | 318 | 252 | 218 | 131 | 140 | 152 | 152 | 161 | 168 | 135 | 90.00 | 98.00 | 105 | 113 | 115 |
Current Assets | -10.2% | 207 | 231 | 244 | 265 | 286 | 299 | 311 | 246 | 212 | 125 | 133 | 146 | 145 | 154 | 161 | 127 | 81.00 | 89.00 | 96.00 | 104 | 110 |
Cash Equivalents | 33.9% | 35.00 | 26.00 | 28.00 | 36.00 | 40.00 | 64.00 | 105 | 39.00 | 63.00 | 57.00 | 26.00 | 23.00 | 21.00 | 13.00 | 17.00 | 21.00 | 15.00 | 20.00 | 13.00 | 18.00 | 24.00 |
Net PPE | -11.2% | 4.00 | 4.00 | 5.00 | 5.00 | 3.00 | 3.00 | 4.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 | 4.00 | 4.00 | 5.00 | 5.00 | 5.00 | 5.00 |
Liabilities | 1.0% | 34.00 | 33.00 | 31.00 | 32.00 | 30.00 | 22.00 | 20.00 | 20.00 | 21.00 | 11.00 | 10.00 | 12.00 | 11.00 | 11.00 | 10.00 | 12.00 | 11.00 | 11.00 | 11.00 | 11.00 | 6.00 |
Current Liabilities | 6.4% | 18.00 | 17.00 | 14.00 | 14.00 | 11.00 | 10.00 | 8.00 | 7.00 | 8.00 | 8.00 | 6.00 | 8.00 | 6.00 | 6.00 | 5.00 | 7.00 | 6.00 | 5.00 | 5.00 | 5.00 | 3.00 |
Long Term Debt | -100.0% | - | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | - | - | - | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | 0.6% | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Shareholder's Equity | -13.2% | 188 | 216 | 232 | 252 | 270 | 283 | 297 | 232 | 197 | 119 | 130 | 141 | 141 | 150 | 158 | 123 | 78.00 | 86.00 | 95.00 | 102 | 109 |
Retained Earnings | -10.1% | -350 | -318 | -295 | -271 | -248 | -230 | -212 | -196 | -180 | -166 | -152 | -139 | -126 | -115 | -103 | -94.30 | -84.28 | -74.70 | -65.56 | -56.84 | -49.19 |
Additional Paid-In Capital | 0.6% | 538 | 535 | 528 | 524 | 520 | 515 | 511 | 430 | 378 | 286 | 282 | 280 | 267 | 265 | 262 | 217 | 163 | 161 | 160 | 159 | 158 |
Shares Outstanding | 0.1% | 73.00 | 73.00 | 73.00 | 71.00 | 68.00 | 66.00 | 64.00 | 61.00 | 56.00 | 52.00 | 52.00 | 51.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | - | 551 | - | - | - | 252 | - | - | - | 174 | - | - | - | 119 | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | 6.1% | -18,980 | -20,205 | -21,600 | -20,860 | -15,883 | -16,360 | -13,289 | -13,314 | -11,081 | -9,954 | -13,045 | -8,357 | -9,307 | -9,250 | -10,091 | -8,301 | -7,210 | -8,255 | -7,712 | -6,700 | -5,473 |
Share Based Compensation | -51.5% | 3,220 | 6,634 | 4,020 | 4,263 | 3,817 | 3,787 | 3,298 | 3,104 | 1,853 | 1,878 | 1,937 | 1,928 | 1,280 | 1,271 | 1,219 | 1,173 | 1,007 | 1,090 | 1,009 | 901 | 449 |
Cashflow From Investing | 50.1% | 27,878 | 18,574 | 13,203 | 16,391 | -8,661 | -24,708 | 1,510 | -59,533 | -82,491 | 38,484 | 16,250 | -687 | 17,318 | 2,790 | -37,276 | -39,330 | 1,678 | 15,623 | 2,142 | 976 | -9,916 |
Cashflow From Financing | 37.2% | 59.00 | 43.00 | 382 | 154 | 506 | 185 | 78,322 | 48,848 | 99,356 | 2,212 | 282 | 10,735 | 317 | 1,962 | 43,995 | 53,368 | 80.00 | 8.00 | 180 | 4.00 | 5.00 |
Consolidated Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021 | |
Income Statement [Abstract] | |||
Collaboration revenue | $ 7,000 | $ 0 | $ 0 |
Operating expenses: | |||
Research and development | 85,697 | 51,009 | 38,935 |
General and administrative | 26,540 | 20,153 | 15,724 |
Restructuring and impairment charges | 6,187 | 0 | 0 |
Total operating expenses | 118,424 | 71,162 | 54,659 |
Loss from operation | (111,424) | (71,162) | (54,659) |
Interest income | 11,104 | 4,108 | 188 |
Interest expense | (1,550) | (1,185) | (159) |
Net loss | $ (101,870) | $ (68,239) | $ (54,630) |
Net loss per common share, Basic | $ (1.4) | $ (1.01) | $ (1.04) |
Net loss per common share, Diluted | $ (1.4) | $ (1.01) | $ (1.04) |
Weighted-average shares used to compute net loss per common share, basic | 72,553,645 | 67,368,935 | 52,759,335 |
Weighted-average shares used to compute net loss per common share, diluted | 72,553,645 | 67,368,935 | 52,759,335 |
Consolidated Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 35,493 | $ 40,456 |
Marketable securities | 165,879 | 236,105 |
Prepaid expenses and other current assets | 5,578 | 9,161 |
Total current assets | 206,950 | 285,722 |
Property and equipment, net | 3,912 | 3,431 |
Operating lease right-of-use asset | 4,778 | 9,741 |
Other assets | 5,595 | 674 |
Total assets | 221,235 | 299,568 |
Current liabilities: | ||
Accounts payable | 8,251 | 2,479 |
Accrued liabilities | 6,481 | 5,953 |
Operating lease liabilities, current | 3,012 | 2,565 |
Total current liabilities | 17,744 | 10,997 |
Operating lease liabilities, noncurrent | 5,852 | 8,865 |
Long-term debt | 10,069 | 9,834 |
Total liabilities | 33,665 | 29,696 |
Stockholders' equity: | ||
Common stock, $0.001 par value, 250,000,000 and 125,000,000 shares authorized as of December 31, 2023 and 2022, respectively; 72,779,077 and 68,493,429 shares issued and outstanding as of December 31, 2023 and 2022, respectively | 73 | 68 |
Preferred stock, $0.001 par value, 10,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2023 and 2022 | 0 | 0 |
Additional paid-in capital | 538,390 | 519,620 |
Accumulated other comprehensive loss | (130) | (923) |
Accumulated deficit | (350,763) | (248,893) |
Total stockholders' equity | 187,570 | 269,872 |
Total liabilities and stockholders' equity | $ 221,235 | $ 299,568 |